Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.10894
Abstract: This secondary analysis of the J-FORCE randomized clinical trial examines the effect of olanzapine plus triplet antiemetic therapy on chemotherapy-induced nausea and vomiting in patients with a malignant tumor, stratified by 6 risk factors. read more here.
Keywords: triplet antiemetic; chemotherapy; efficacy olanzapine; antiemetic therapy ... See more keywords
Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-019-03831-4
Abstract: PurposeWe aimed to investigate the efficacy of 0.25 mg dose of palonosetron and granisetron in triplet antiemetic prophylaxis in breast cancer patients receiving HEC.MethodsPatients with nonmetastatic breast cancer who received HEC [doxorubicin or epirubicin plus cyclophosphamide… read more here.
Keywords: cancer; palonosetron granisetron; study; triplet antiemetic ... See more keywords